To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI

NCT02145897 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

BIOLOGICAL: Autologous Stromal Vascular Fraction (SVF)
BIOLOGICAL: Autologous Adipose Derieved MSCs
OTHER: Control

Sponsor

Kasiak Research Pvt. Ltd.